News
-
-
PRESS RELEASE
Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs
Samfara completes acquisition of Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance APIs. European life sciences investment firm backs deal with institutional investors and family offices